With a $3.9 billion market value, Medidata Solutions (NASDAQ:MDSO) ranks in the top quarter of its industry group, Health Care Technology, and in the top quarter of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, Portfolio Grader's current ranking for MDSO puts it 11 among the 24 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 320 among the 782 companies in the sector, and number 1,807 in the nearly 5,000 company Portfolio Grader universe.

Medidata Solutions (NASDAQ:MDSO) is ranked as a Hold using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methods. MDSO has maintained this ranking for 3 months.

The current recommendation of Hold for Medidata Solutions (NASDAQ:MDSO) has been derived by using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking MDSO has had from Portfolio Grader for 3 months.

Portfolio Grader currently ranks Medidata Solutions (NASDAQ:MDSO) a Hold. Using Louis Navellier's investing methodology, this analytical tool assesses stocks by means of fundamental and quantitative metrics. MDSO has maintained this ranking for 3 months.

Portfolio Grader currently ranks Medidata Solutions (NASDAQ:MDSO) a Hold. The methodology for investing incorporated in this analytical tool developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

With a $4.2 billion market value, Medidata Solutions (NASDAQ:MDSO) ranks in the top quarter of its industry group, Health Care Technology, and in the top quarter of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, Portfolio Grader's current ranking for MDSO puts it 10 among the 25 companies in this industry group, giving it an above-average position; in the top half of the sector with a ranking of 269 among the 783 companies in the sector, and number 1,867 in the nearly 5,000 company Portfolio Grader universe.

Portfolio Grader currently ranks Medidata Solutions (NASDAQ:MDSO) a Buy. Using Louis Navellier's investing methods, this analytical tool assesses stocks with fundamental and quantitative metrics. MDSO has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

The current recommendation of Buy for Medidata Solutions (NASDAQ:MDSO) is derived using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing approach. The shares have been upgraded from a Hold to a Buy in the last week.

Currently, Medidata Solutions (NASDAQ:MDSO) has a Hold using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Currently, Medidata Solutions (NASDAQ:MDSO) has a Hold using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.